CANC vs. XBI ETF Comparison
Comparison of Tema Oncology ETF (CANC) to SPDR S&P Biotech ETF (XBI)
CANC
Tema Oncology ETF
CANC Description
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$28.10
Average Daily Volume
4,338
Number of Holdings
*
7
* may have additional holdings in another (foreign) market
XBI
SPDR S&P Biotech ETF
XBI Description
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a replication strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.Grade (RS Rating)
Last Trade
$97.51
Average Daily Volume
7,364,590
Number of Holdings
*
10
* may have additional holdings in another (foreign) market
Performance
| Period | CANC | XBI |
|---|---|---|
| 30 Days | -3.87% | -1.01% |
| 60 Days | 2.48% | 4.38% |
| 90 Days | 4.04% | 6.34% |
| 12 Months | 21.64% | 35.36% |
CANC: Top Represented Industries & Keywords
XBI: Top Represented Industries & Keywords
Compare ETFs
